Please use a PC Browser to access Register-Tadawul
Get It
Earnings Outlook For PTC Therapeutics
PTC Therapeutics, Inc. +2.73%
PTC Therapeutics, Inc. PTCT | 70.27 | +2.73% |
PTC Therapeutics (NASDAQ:PTCT) will release its quarterly earnings report on Thursday, 2026-02-19. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate PTC Therapeutics to report an earnings per share (EPS) of $-0.33.
PTC Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
The company's EPS beat by $1.34 in the last quarter, leading to a 5.98% increase in the share price on the following day.
Here's a look at PTC Therapeutics's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.14 | -1.07 | -0.70 | -0.65 |
| EPS Actual | 0.20 | -0.83 | 10.04 | -0.85 |
| Price Change % | 6.00 | -10.00 | 13.00 | 9.00 |
Market Performance of PTC Therapeutics's Stock
Shares of PTC Therapeutics were trading at $69.17 as of February 17. Over the last 52-week period, shares are up 37.92%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for PTC Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
